January's Top Rx Pharma Brands by TV Ad Spend
With $41.3 million in estimated national TV ad spend, Rinvoq was the top-spending Rx brand in January.
Rinvoq, an AbbVie JAK inhibitor immunology drug, was the No. 1 prescription pharmaceutical brand when it came to estimated national TV ad spend in January, according to iSpot.tv data shared with FiercePharma. It spent about $41.3 million, up slightly from December's outlay of $40.6 million. Rinvoq was also the top-spending Rx brand for 2022 overall.
Some additional insights around TV ads from the top pharma brands in January:
- In total, the top ten brands spent about $207.4 million, an increase from January 2022's $188.1 million.
- Skyrizi moves into second place from fourth in December, spending an estimated $37.7 million, up from $16.9 million the previous month.
- Rexulti, an antipsychotic drug from Lunbeck and Otsuka, was a month-over-month ranking newcomer with an estimated spend of $12.5 million after not spending at all on national TV in December.
